Arteriosclerosis: Clinical Trials

7,708 trials for Arteriosclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4101 completed, 1516 unknown, 771 recruiting, 429 terminated. 2766 Not applicable, 899 Phase 4, 615 Phase 2, 576 Phase 3, 301 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2766Completed 1400, Unknown 520, Recruiting 307, Not yet recruiting 158, Terminated 148, Active not recruiting 135, Withdrawn 76, Enrolling by invitation 14, Suspended 8
Phase 4899Completed 492, Unknown 213, Terminated 78, Recruiting 60, Withdrawn 26, Active not recruiting 14, Not yet recruiting 14, Enrolling by invitation 1, Suspended 1
Phase 2615Completed 385, Unknown 118, Terminated 39, Recruiting 34, Withdrawn 18, Not yet recruiting 13, Active not recruiting 7, Suspended 1
Phase 3576Completed 353, Unknown 90, Terminated 55, Recruiting 29, Active not recruiting 23, Not yet recruiting 13, Withdrawn 10, Suspended 2, Enrolling by invitation 1
Phase 1301Completed 198, Unknown 50, Terminated 21, Withdrawn 14, Recruiting 12, Not yet recruiting 4, Active not recruiting 2
Early Phase 147Completed 25, Unknown 8, Recruiting 5, Terminated 3, Enrolling by invitation 2, Not yet recruiting 2, Withdrawn 2

Follow Arteriosclerosis: new trials by email Literature Review of Arteriosclerosis trials Research Report on Arteriosclerosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
FGF-1, Placebo - Peripheral Arterial Disease, Stenosis
Phase 1 / Phase 2Not yet recruitingVenturis Therapeutics, Inc.242028-10-152026-08-19
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
Vitamin B6 25 MG, Vitamin B6 50 MG, Vitamin B6 100 MG - Ischemia Reperfusion Injury, Peripheral Artery Disease
Early Phase 1Not yet recruitingMilton S. Hershey Medical Center302027-12-012026-03-17
Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease
Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141) - low dose, Human Recombinant Fibroblast Growth Factor-1 (FGF1-141) - high dose, Placebo - Coronary Disease, Coronary Heart Disease
Phase 2Not yet recruitingVenturis Therapeutics, Inc.1502027-09-012026-08-19
EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease
Encephaloduroarteriosynangiosis (EDAS), Intensive medical management - Intracranial Atherosclerosis, Intracranial Arterial Stenosis
Not applicableNot yet recruitingCedars-Sinai Medical Center1702027-05-012026-10-13
Heart tEam Decision-making Assisted by Revaz AI Trial
Revaz AI - Coronary Artery Disease
Not applicableNot yet recruitingUniversity of Calgary7122027-04-012026-09-24
OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation
Oral anticoagulation, Single antiplatelet therapy - Atrial Fibrillation (AF), Coronary Artery Disease
Phase 4Not yet recruitingEwha Womans University Mokdong Hospital22027-03-012026-03-27
PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis
Hyperlipidemia, Atherosclerotic Cardiovascular Disease (ASCVD)
Not yet recruitingFundación Santa Fe de Bogota1002027-02-012026-10-02
A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma
Evolocumab, Routine Lipid Management, Autoinjector - Coronary Artery Disease, Hypercholesterolemia
Phase 4Not yet recruitingAmgen3082027-01-312026-09-21
Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease
RespirAct - Coronary Artery Disease
Not applicableNot yet recruitingIndiana University302027-01-102026-05-26
RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling
Intervention 1, Intervention 3, Intervention 2 - Atherosclerosis Cerebral, Carotid Plaque
Phase 4Not yet recruitingKeqiang Zhao1202027-01-012026-09-15
Nursing Intervention for Adaptation After Myocardial Revascularization
Nursing Intervention Program, Usual Care - Coronary Artery Disease, Myocardial Revascularization
Not applicableNot yet recruitingUniversidad de la Sabana402027-01-012026-05-08
Photobiomodulation in Coronary Artery Bypass Grafting With No-Touch vs Conventional Saphenous Vein Harvesting.
Photobiomodulation Therapy, Sham Laser irradiation, Conventional Saphenous Vein Harvesting - Coronary Artery Disease, Coronary Artery Bypass Graft (CABG)
Not applicableNot yet recruitingFederal University of São Paulo2922027-01-012026-10-07
Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and Cost-Effectiveness Assessment
Lipid-lowering therapy targeting LDL-C <1.0 mmol/L, Lipid-lowering therapy targeting LDL-C 1.0-1.39 mmol/L - Atherosclerotic Cardiovascular Disease (ASCVD)
Not applicableNot yet recruitingBeijing Anzhen Hospital60002027-01-012026-05-29
Intraoperative Ultrasound Assessment of Coronary Artery and Bypass Graft Blood Flow During CABG
Intraoperative Ultrasound Blood Flow Measurement - Coronary Artery Disease
Not yet recruitingThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1902027-01-012026-08-11
Drug-coated Balloons Versus Drug-eluting Stents for the Treatment of Femoropopliteal In-Stent Restenosis
Drug-Coated Balloon-First Strategy, Eluvia Drug-Eluting Stent-First Strategy - Femoropopliteal In-Stent Restenosis (ISR)
Not yet recruitingChunshui He6002027-01-012026-09-16
wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65
Arm 1: wCAR-CARE - Precision Prevention (Arm A), Guideline-directed standard of care - Cardiovascular Diseases (CVD), Coronary Artery Disease
Not applicableNot yet recruitingWomen's Heart Austria8002027-01-012026-09-30
Modified Jailed Balloon Technique vs Jailed Wire Technique in Coronary Bifurcation Intervention
jailed wire technique, Modified jailed balloon technique - Coronary Artery Disease
Not applicableNot yet recruitingAssiut University1402027-01-012026-10-14
Rapid Inflation/Deflation Compared With Prolonged High-Pressure Balloon Inflation
Prolonged inflation, Rapid inflation - Coronary Artery Disease, Coronary Stent Occlusion
Not applicableNot yet recruitingCentral Arkansas Veterans Healthcare System402027-01-012026-10-21
Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma
Statins (atorvastatin, rosuvastatin, simvastatin, or pravastatin), +/- ezetimibe, +/- PCSK9 inhibitor (alirocumab, evolocumab, inclisiran) - Melanoma
Not applicableRecruitingUniversity of Colorado, Denver402026-12-312026-08-07
FRAME, External Support for Lower Limb Autologous Grafts
FRAME - Peripheral Arterial Disease, Peripheral Artery Disease
Not applicableSuspendedVascular Graft Solutions Ltd.302026-12-312025-02-04

Showing 20 of 7708. Sign in to see all of them.

Narrower conditions

Coronary Artery Disease (4728)  ·  Atherosclerosis (1482)  ·  Peripheral Arterial Disease (1356)  ·  Cardiovascular Diseases (672)  ·  Myocardial Ischemia (407)  ·  Coronary Disease (403)  ·  Myocardial Infarction (373)  ·  Chronic Limb-Threatening Ischemia (353)  ·  Diabetes Mellitus (338)  ·  Heart Diseases (328)  ·  Acute Coronary Syndrome (260)  ·  Intermittent Claudication (222)  ·  Peripheral Vascular Diseases (215)  ·  Stroke (209)  ·  Angina Pectoris (206)

Broader conditions

Arterial Occlusive Diseases (7579)  ·  Vascular Diseases (7537)  ·  Cardiovascular Diseases (7036)  ·  Heart Diseases (4722)  ·  Myocardial Ischemia (4540)  ·  Coronary Disease (4431)  ·  Pathological Conditions, Signs and Symptoms (2196)  ·  Pathologic Processes (1512)  ·  Atherosclerosis (1474)  ·  Peripheral Vascular Diseases (1399)  ·  Nutritional and Metabolic Diseases (915)  ·  Signs and Symptoms (880)  ·  Metabolic Diseases (857)  ·  Ischemia (793)

Interventions

Clopidogrel (216)  ·  Aspirin (185)  ·  Percutaneous Coronary Intervention (160)  ·  Ticagrelor (115)  ·  Atorvastatin (102)  ·  Exercise (87)  ·  Rosuvastatin Calcium (77)  ·  Prasugrel Hydrochloride (60)  ·  Ezetimibe (59)  ·  Drug-Eluting Stents (54)  ·  Stents (51)  ·  Angioplasty (49)  ·  Coronary Artery Bypass (49)  ·  Simvastatin (42)  ·  Standard of Care (41)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (126)  ·  Abbott Medical Devices (97)  ·  Yonsei University (75)  ·  Boston Scientific Corporation (61)  ·  China National Center for Cardiovascular Diseases (59)  ·  Seung-Jung Park (58)  ·  Cordis US Corp. (48)  ·  University of Florida (47)  ·  Seoul National University Hospital (46)  ·  Ottawa Heart Institute Research Corporation (41)  ·  Assiut University (40)  ·  AstraZeneca (40)  ·  Massachusetts General Hospital (38)  ·  Insel Gruppe AG, University Hospital Bern (36)  ·  Mayo Clinic (36)

Countries

United States (2042)  ·  China (771)  ·  Germany (609)  ·  Italy (456)  ·  South Korea (454)  ·  United Kingdom (446)  ·  France (409)  ·  Netherlands (408)  ·  Canada (396)  ·  Spain (308)  ·  Belgium (299)  ·  Denmark (250)  ·  Switzerland (234)  ·  Brazil (219)  ·  Austria (209)

Top investigators

Seung-Jung Park, MD, PhD (31)  ·  Bon-Kwon Koo, MD, PhD (18)  ·  Marc Bosiers, MD (13)  ·  Koen Deloose, MD (12)  ·  Dominick J Angiolillo, MD, PhD (11)  ·  Gregg W Stone, MD (11)  ·  Ron Waksman, MD (11)  ·  David Kandzari, MD (10)  ·  Mary McDermott, MD (10)  ·  Shao-Liang Chen, MD (10)  ·  Shigeru Saito, MD (10)

Results publications

PMID 42573020, PMID 35224730, PMID 40875095, PMID 42035974, PMID 25940520, PMID 31567024, PMID 24746650, PMID 19463432, PMID 20142198, PMID 23468513, PMID 23523454, PMID 23636237, PMID 30690141, PMID 31543165, PMID 33025243, PMID 35802393, PMID 36588397, PMID 37565307, PMID 17296825, PMID 23232250, PMID 24510638, PMID 26354543, PMID 26825231, PMID 29089314, PMID 30165437, PMID 31561250, PMID 32227755, PMID 32609313, PMID 32890442, PMID 33939604, PMID 34056911, PMID 35641327, PMID 35916348, PMID 36137674, PMID 37256598, PMID 37619976, PMID 37745109, PMID 39329200, PMID 40590244, PMID 41913985, PMID 17145250, PMID 17223489, PMID 17982182, PMID 18765162, PMID 19228612, PMID 19717846, PMID 20129555, PMID 21232717, PMID 21670242, PMID 22017936

NIH funding

2025 (15), 2017 (11), 2023 (10), 2009 (8), 2016 (8), 2015 (6), 2018 (6), 2014 (5), 2019 (5), U01HL088942 (4), 2005 (3), R01AG031750 (3), R01HL092954 (3), 2004 (2), 2008 (2)